About Second Sight
Second Sight is a company based in Los Angeles (United States) founded in 2000.. Second Sight has raised $52.3 million across 23 funding rounds from investors including NIH and HHS. The company has 14 employees as of December 31, 2022. Second Sight has completed 1 acquisition, including Nano Precision Medical. Second Sight operates in a competitive market with competitors including Kodiak Sciences, Pixium Vision, Eyedaptic, iScience Interventional and Medical Instrument Development Laboratories, among others.
- Headquarter Los Angeles, United States
- Employees 14 as on 31 Dec, 2022
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$52.3 M (USD)
in 23 rounds
-
Latest Funding Round
$1.1 M (USD), Grant
Jul 18, 2022
-
Investors
NIH
& 1 more
-
Employee Count
14
as on Dec 31, 2022
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of Second Sight
Second Sight has successfully raised a total of $52.3M across 23 strategic funding rounds. The most recent funding activity was a Grant round of $1.1 million completed in July 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 23
- Last Round Grant — $1.1M
-
First Round
First Round
(01 Jul 2000)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2022 | Amount | Grant - Second Sight | Valuation |
investors |
|
| May, 2021 | Amount | Grant - Second Sight | Valuation |
investors |
|
| Mar, 2021 | Amount | Post-IPO - Second Sight | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Second Sight
Second Sight has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include NIH and HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Drug discovery services are provided to the biopharma sector.
|
Founded Year | Domain | Location | |
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Second Sight
Second Sight has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Nano Precision Medical. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Titanium capsule to provide constant rate delivery of therapeutic
|
2009 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Second Sight
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Second Sight Comparisons
Competitors of Second Sight
Second Sight operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Kodiak Sciences, Pixium Vision, Eyedaptic, iScience Interventional and Medical Instrument Development Laboratories, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutics for retinal diseases are developed by the company.
|
|
| domain | founded_year | HQ Location |
Bionic vision restoration systems are provided for sight restoration.
|
|
| domain | founded_year | HQ Location |
A wearable augmented reality vision assistance solution
|
|
| domain | founded_year | HQ Location |
Microcatheter and imaging technologies for ophthalmic procedures are developed.
|
|
| domain | founded_year | HQ Location |
Develops ophthalmic products for ophthalmic system manufacturers
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Second Sight
Frequently Asked Questions about Second Sight
When was Second Sight founded?
Second Sight was founded in 2000.
Where is Second Sight located?
Second Sight is headquartered in Los Angeles, United States. It is registered at Los Angeles, California, United States.
Who is the current CEO of Second Sight?
Adam Mendelsohn is the current CEO of Second Sight.
Is Second Sight a funded company?
Second Sight is a funded company, having raised a total of $52.3M across 23 funding rounds to date. The company's 1st funding round was a Post-IPO of $27.9M, raised on Jul 01, 2000.
How many employees does Second Sight have?
As of Dec 31, 2022, the latest employee count at Second Sight is 14.
What does Second Sight do?
Provider of implantable visual prosthetics for blind individuals. The flagship product, Argus II Retinal Prosthesis System is an FDA and CE-approved device targeted for patients with severe to profound retinitis pigmentosa. Includes a miniature video camera housed in the patients glasses, a patient-worn computer where data is processed and transformed into instructions transmitted wirelessly to an antenna in the retinal implant. The implant emits electrical pulses which create perceptions of patterns of light. Patients learn to interpret these visual patterns with their retinal implant. It is also developing the Visual Cortical Prosthesis, Orion for blinds due to preventable or treatable conditions.
Who are the top competitors of Second Sight?
Second Sight's top competitors include Kodiak Sciences, Pykus Therapeutics and Pixium Vision.
How many acquisitions has Second Sight made?
Second Sight has made 1 acquisition, including Nano Precision Medical.